The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?

被引：173

作者：

Combe, R ^{[1
]}

Bramwell, S ^{[1
]}

Field, MJ ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Pain Therapeut, Sandwich CT13 9NJ, Kent, England

来源：

NEUROSCIENCE LETTERS | 2004年 / 370卷 / 2-3期

关键词：

osteoarthritis; punctate allodynia; dynamic allodynia; weight bearing; nociceptive pain;

D O I：

10.1016/j.neulet.2004.08.023

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Osteoarthritis (OA) is a widespread condition affecting the elderly population. One of the most prominent features but least studied symptoms is chronic pain associated with OA. The study objective was to determine pain endpoints in rats with monosodium iodoacetate (MIA) induced OA, and to investigate the efficacy of common nociceptive agents. Sprague-Dawley rats received an intraarticular injection of either 25 mul 80 mg/ml MIA or 25 mul 0.9% sterile saline into the right knee joint. Changes in von Frey thresholds and latencies to stroking with a cotton bud (punctate and dynamic allodynia, respectively) were measured pre- and for up to 10 weeks post-intraarticular injection. Changes in hind paw weight distribution were also determined. Both punctate allodynia and a weight bearing deficit were observed in MIA-treated rats for up to 10 weeks. Interestingly, dynamic allodynia was not detected at any time point tested. Morphine (0.3-3 mg/kg, s.c.) and tramadol (3-100 mg/kg, p.o.) dose-dependently inhibited punctate allodynia and partially reversed weight bearing deficit. In conclusion, the MIA model of OA is reproducible and mimics OA pain in humans. Analgesic drug studies indicate this model may be useful for investigating chronic nociceptive pain. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

引用

页码：236 / 240

页数：5

共 22 条

[1] A PERIPHERAL MONONEUROPATHY IN RAT THAT PRODUCES DISORDERS OF PAIN SENSATION LIKE THOSE SEEN IN MAN [J].

BENNETT, GJ ;

XIE, YK .

PAIN, 1988, 33 (01) :87-107

[2] Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis [J].

Bove, SE ;

Calcaterra, SL ;

Brooker, RM ;

Huber, CM ;

Guzman, RE ;

Juneau, PL ;

Schrier, DJ ;

Kilgore, KS .

OSTEOARTHRITIS AND CARTILAGE, 2003, 11 (11) :821-830

[3] Osteoarthritis I: Epidemiological risk factors and historical considerations [J].

Buchanan W.W. ;

Kean W.F. .

InflammoPharmacology, 2002, 10 (1-2) :5-21

[4]

Buchanan WW, 2002, INFLAMMOPHARMACOLOGY, V10, P19

[5]

Dalgin Paul, 1997, Arthritis and Rheumatism, V40, pS86

[6]

DUBNER R, 1995, P 6 WORLD C PAIN, P263

[7]

DUNHAM J, 1993, INT J EXP PATHOL, V74, P283

[8] Detection of static and dynamic components of mechanical allodynia in rat models of neuropathic pain: are they signalled by distinct primary sensory neurones? [J].

Field, MJ ;

Bramwell, S ;

Hughes, J ;

Singh, L .

PAIN, 1999, 83 (02) :303-311

[9]

Gencosmanoglu BE, 2001, RES EXP MED, V200, P215

[10] Mono-iodoacetate-induced experimental osteoarthritis - A dose-response study of loss of mobility, morphology, and biochemistry [J].

Guingamp, C ;

GegoutPottie, P ;

Philippe, L ;

Terlain, B ;

Netter, P ;

Gillet, P .

ARTHRITIS AND RHEUMATISM, 1997, 40 (09) :1670-1679

← 1 2 3 →